Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Rubicon Research Private Limited operates a patent portfolio in the Biotechnology & Pharmaceuticals sector. The portfolio currently has 2 pending office actions. These actions are spread across 2 distinct examiners and 2 distinct art units. This distribution indicates that the company is pursuing multiple technological paths within the biotechnology field.
BARHAM, BETHANY P is the busiest examiner for the portfolio, overseeing 1 pending office action. With 2 pending office actions in total, the workload is divided among multiple examiners and art units, which suggests a broader prosecution front for the company's current pharmaceutical research.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YOUNG, MICAH PAUL | 1 | 55.1% | +30.0% |
| BARHAM, BETHANY P | 1 | 51.7% | +32.1% |
| COHEN, MICHAEL P | 1 | 58.7% | +27.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19081940 | SUSTAINED RELEASE COMPOSITIONS | YOUNG, MICAH PAUL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16943851 | GASTRORETENTIVE FORMULATIONS | COHEN, MICHAEL P | 119d overdue |
| 17445992 | MODIFIED RELEASE FORMULATIONS OF LEVODOPA | BARHAM, BETHANY P | 54d |
| 19081940 | SUSTAINED RELEASE COMPOSITIONS | YOUNG, MICAH PAUL | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19081940 | SUSTAINED RELEASE COMPOSITIONS | YOUNG, MICAH PAUL | — | §102§103 | Non-Final OA | — | Pending | Mar 17, 2025 |
| 17445992 | MODIFIED RELEASE FORMULATIONS OF LEVODOPA | BARHAM, BETHANY P | 1611 | §103Other | Final Rejection | 54d | Pending | Aug 26, 2021 |
| 16943851 | GASTRORETENTIVE FORMULATIONS | COHEN, MICHAEL P | 1612 | §103 | Final Rejection | 119d overdue | Pending | Jul 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial